Skip to main content
Clinical Trials/CTRI/2023/03/051035
CTRI/2023/03/051035
Completed
Phase 4

A Cross over, Double blinded, Interventional study to evaluate the skin sensitivity, safety and tolerability of two types of Amrutanjan Pain Balm in healthy subjects

Amrutanjan Health Care Limited, Tamil Nadu, India.0 sites12 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Amrutanjan Health Care Limited, Tamil Nadu, India.
Enrollment
12
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 25, 2023
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Amrutanjan Health Care Limited, Tamil Nadu, India.

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients of either sex aged above 18 years.
  • 2\.Patients who are able to understand written and/or verbal instructions and are ready to comply with all study requirements with a willingness to participate and give written informed consent voluntarily.

Exclusion Criteria

  • 1\.Past history of allergy, asthma and atopy.
  • 2\.Known allergy to compounds of investigational product.
  • 3\.Participation in an investigational drug trial in the 30 days prior to the screening visit.
  • 4\.Patients of vulnerable group (children, lactating mother, elderly \>80 years, handicapped, seriously ill, mentally challenged).
  • 5\.Subjects with known history of Sinusitis, Migraine.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
PROLIFIC - A post-acute COVID syndrome studyPatients with Post-Acute COVID syndrome (PACS) in which extensive clinical and biochemical examinations have been performed. PACS patients experience a wide variety of symptoms related to physical and cognitive function, including fatigue, dyspnea, brain fog” or other cognitive symptoms, pain, depression, and gastrointestinal issues which significantly impact quality of life.MedDRA version: 20.1Level: HLTClassification code 10047483Term: Viral upper respiratory tract infectionsSystem Organ Class: 100000004855Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2022-003855-32-SEKarolinska Institutet400
Recruiting
Not Applicable
A clinical trial to compare the denture made from conventional and digital impression technique.
CTRI/2021/08/035587Maulana Azad Institute of Dental Sciences
Not yet recruiting
Phase 2
Comparison of Levobupivacaine with Fentanyl vs Ropivacaine with Fentanyl in Thoracic Epidural for post thoracotomy pain reliefHealth Condition 1: J00-J99- Diseases of the respiratory system
CTRI/2020/07/026296Department of Anaesthesia SMS Medical College
Completed
Phase 4
Clinical Study to check the Skin Safety and Efficacy of Aloe Wound Healing Ointment for Wound Healing.Health Condition 1: R238- Other skin changes
CTRI/2023/11/059901niversity of Pretoria30
Completed
Phase 3
To evaluate the efficacy of face wash, face scrub and face mask when used in combination, to give Clear pores effect on healthy female subjects.
CTRI/2013/02/003419Hindustan Unilever Limited40